Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
about
Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRTEPID dosimetry for pretreatment quality assurance with two commercial systems.Report on use of a methodology for commissioning and quality assurance of a VMAT systemA six-year review of more than 13,000 patient-specific IMRT QA results from 13 different treatment sites.Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic fieldThe MapCHECK Measurement Uncertainty function and its effect on planar dose pass rates.3D VMAT Verification Based on Monte Carlo Log File Simulation with Experimental Feedback from Film DosimetryValidation of an improved helical diode array and dose reconstruction software using TG-244 datasets and stringent dose comparison criteria.Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.Comparisons of volumetric modulated arc therapy (VMAT) quality assurance (QA) systems: sensitivity analysis to machine errors.Evaluation of the radiobiological gamma index with motion interplay in tangential IMRT breast treatmentIn vivo dosimetry in external beam radiotherapy.Dosimetric and radiobiological comparison for quality assurance of IMRT and VMAT plans.VMAT QA: Measurement-guided 4D dose reconstruction on a patient.Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index.Technical Note: Relationships between gamma criteria and action levels: Results of a multicenter audit of gamma agreement index results.Evaluation of dosimetric effect caused by slowing with multi-leaf collimator (MLC) leaves for volumetric modulated arc therapy (VMAT).Incorporation of gantry angle correction for 3D dose prediction in intensity-modulated radiation therapy.Breaking bad IMRT QA practice.Dosimetric validation and clinical implementation of two 3D dose verification systems for quality assurance in volumetric-modulated arc therapy techniques.Three-dimensional polymer gel dosimetry using an onboard 0.35 T magnetic resonance imaging scanner: A simulation study.Correcting lateral response artifacts from flatbed scanners for radiochromic film dosimetry.Curtailing patient-specific IMRT QA procedures from 2D dose error distribution.Evaluation of a software system for estimating planned dose error in patients, based on planar IMRT QA measurements.Dosimetric verification by using the ArcCHECK system and 3DVH software for various target sizes.Comparison of dose calculations between pencil-beam and Monte Carlo algorithms of the iPlan RT in arc therapy using a homogenous phantom with 3DVH software.Independent calculation of monitor units for VMAT and SPORT.Evaluating IMRT and VMAT dose accuracy: practical examples of failure to detect systematic errors when applying a commonly used metric and action levels.Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: clinical head and neck case studies.A comparison of the dosimetric effects of intrafraction motion on step-and-shoot, compensator, and helical tomotherapy-based IMRT.Efficient and reliable 3D dose quality assurance for IMRT by combining independent dose calculations with measurements.Evaluation of the accuracy of 3DVH software estimates of dose to virtual ion chamber and film in composite IMRT QA.On the sensitivity of common gamma-index evaluation methods to MLC misalignments in Rapidarc quality assurance.IMRT QA: Selecting gamma criteria based on error detection sensitivity.ROC analysis in patient specific quality assurance.Organ-specific modulation complexity score for the evaluation of dose delivery.Correlation of phantom-based and log file patient-specific QA with complexity scores for VMAT.X-Tream quality assurance in synchrotron X-ray microbeam radiation therapy.Investigation of error detection capabilities of phantom, EPID and MLC log file based IMRT QA methods.
P2860
Q30303160-1F9BABC4-0D84-420F-BC36-8FC44CA35DBBQ33987639-1C20D645-6FAE-4A99-8BC7-7ED47A9F90BBQ34327663-17C5A992-8790-4AAA-B1D2-ABCA9715184EQ34648475-8C7039DE-3F78-40A1-891C-0483528208ADQ34815741-D73FD708-773B-4425-AEE5-B47866EEE2B4Q35268552-E7D9B329-2CA9-4ADF-A1C4-5F8BA9B5FF97Q35988656-E6B1DE11-5A58-4ECD-BAFC-D61C79C42D4FQ36199742-EC68FE3F-C77B-4349-8387-F2BC3F0FD13AQ36215724-C352DFB6-0562-4BBF-88B0-6395AB4260D8Q36295222-7AF24BE1-9A01-45DD-8785-17D52AFE5AC4Q37400519-C82A78E7-5502-4E19-896E-8BF0F22244EEQ37472691-ED9099A5-E662-4F06-A32B-3FBCD6118051Q38119002-AB6E391B-3885-4663-9545-E2AA0FE33C63Q38644060-48556982-03AB-4EE5-8AB6-30A8017DD57FQ38779267-4F4B3F33-E2D6-48AD-B631-38D9F12269D9Q39603375-A4E1B446-4B15-4EF6-BB1C-71541A0982FCQ39952145-290A8258-DC8A-4239-B1ED-0C926E3F319EQ39978356-74BD12F3-78BC-4DC8-883D-069E43D932E6Q40521147-D4DB2D32-7E36-472D-AE19-B7A9CF5DF58CQ40807290-A6FA9F4A-F6A2-4167-8CBE-243816B149F9Q40807461-20FD2FAF-BC95-436F-80E4-08B3D79F056AQ41287947-0842FE52-8874-4A73-8D3A-5DF07A73338BQ41618775-A74A8051-675F-4626-A507-E55AEEB48F6CQ41858225-CF64204D-FC00-4CF4-BBBB-7CB4ABF9C28CQ41903852-872342DE-ABC4-4460-8110-FFA42C790941Q42123759-AC033CB3-0F1C-47EE-ADF2-1B115A1E5FD9Q43010241-40F62139-5FDB-49D8-B334-4EB228D9AFCCQ43125130-BC2EE8A9-26C9-4467-B7A0-32AEEC53B2CCQ44127680-4A53AE7B-EA8A-4DC1-88CD-628A2DC45863Q44260455-3BFAF086-8CF4-43DB-9838-748D7E1449D2Q44648147-6061A9BB-4A67-491E-A9A4-9B7B515303E1Q44949068-9DBB0EBF-12B1-4796-AD90-5E7F8F0F127AQ45944592-5EA33BA9-2201-40AD-951B-F8A497ABE526Q45985919-B0A71B27-4697-4A33-950F-B8B7F6DD2F19Q46419336-547CE1F6-4CEC-4698-81EB-593A8FD790C3Q46991357-D60917A4-BB40-4924-BA9F-9C078A678766Q47097140-CEF37200-48AC-41F9-9428-D1020A12E042Q47698300-E5A36C92-1005-40D9-A85C-B45A0F43B7BEQ47700035-5AECB5DF-12EF-4190-9819-5B3E5904CB75Q48506501-EAB0EFCF-5105-4D30-82F3-0C6CAA893725
P2860
Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
@en
Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
@nl
type
label
Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
@en
Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
@nl
prefLabel
Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
@en
Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
@nl
P2860
P356
P1433
P1476
Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
@en
P2093
Benjamin E Nelms
Heming Zhen
P2860
P304
P356
10.1118/1.3633904
P407
P50
P577
2011-10-01T00:00:00Z